Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Chemicals & Petrochemicals | Small Cap
Health Score : 5.80Camlin Fine Sciences demonstrates a mixed financial performance. The company shows strong solvency, indicating it manages its debt well. Profitability metrics are generally positive, driven by healthy gross and operating margins, as well as a solid return on assets. However, there are challenges related to efficiency, particularly in asset turnover and inventory management. Growth metrics are highly variable, with strong revenue and asset growth offset by declines in EPS and net income. Coverage ratios are weak, and financial metrics like adjusted EPS and cash EPS are also concerning. Overall, the company exhibits financial stability and some profitability, but needs to improve operational efficiency and earnings performance.
Health Score : 5.80Camlin Fine Sciences demonstrates a mixed financial performance. The company shows strong solvency, indicating it manages its debt well. Profitability metrics are generally positive, driven by healthy gross and operating margins, as well as a solid return on assets. However, there are challenges related to efficiency, particularly in asset turnover and inventory management. Growth metrics are highly variable, with strong revenue and asset growth offset by declines in EPS and net income. Coverage ratios are weak, and financial metrics like adjusted EPS and cash EPS are also concerning. Overall, the company exhibits financial stability and some profitability, but needs to improve operational efficiency and earnings performance.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
-59.38
Industry Median
39.73
Small Cap Median
37.95
P/E RATIO
70.93
P/B RATIO
1.88
Industry Median
2.59
Small Cap Median
2.40
P/S RATIO
1.08
Industry Median
2.52
Small Cap Median
2.34
Others
PEG RATIO
0.00
EV/EBITDA RATIO
12.37
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹102.14 as on Sep 1, 2026.
Growth Score : 6.00The company has mixed growth metrics. It shows high growth potential with strong revenue and asset growth. However, there is a sharp decline in EPS and net income growth. The company is growing in terms of revenue and assets, but profitability is declining.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthPoorAsset Growth RateExcellentNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue Growth Rate | 18.96 | 19.12 | -13.56 | 14.65 | 3.36 |
| Operating Profit Growth Rate | -15.51 | 33.54 | -19.43 | 29.41 | -51.36 |
| Earnings Per Share (EPS) Growth | -3.09 | -14.2 | -266.89 | -49.8 | 119.46 |
| Asset Growth Rate | 21.36 | 14.25 | -3.57 | 3.3 | 14.09 |
| Net Income Growth Rate | -7.69 | -33.33 | -362.5 | -50.48 | 115.19 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | J.G.Chemicals Ltd | 9.23 | 37.26 | Neutral | 82.00 | 5.47 | 69.00 |
| 2 | Platinum Industries Ltd | 8.59 | 24.08 | Neutral | 60.00 | 9.75 | 51.00 |
| 3 | Rossari Biotech Ltd | 8.46 | 17.69 | Neutral | 286.00 | 25.79 | 149.00 |
| 4 | Fineotex Chemical Ltd | 8.39 | 52.51 | Neutral | 135.00 | 0.79 | 125.00 |
| 5 | Vidhi Specialty Food Ingredients Ltd | 8.25 | 36.16 | Neutral | 78.00 | 9.84 | 49.00 |
| 6 | Bhansali Engineering Polymers Ltd | 8.25 | 17.56 | Undervalued | 216.00 | 7.25 | 180.00 |
| 7 | Styrenix Performance Materials Ltd | 8.12 | 19.35 | Neutral | 463.00 | 180.10 | 273.00 |
| 8 | Balaji Amines Ltd | 7.71 | 46.70 | Overvalued | 265.00 | 51.09 | 169.00 |
| 9 | Tatva Chintan Pharma Chem Ltd | 7.13 | 89.27 | Highly Overvalued | 93.00 | 16.71 | 42.00 |
| 10 | Neogen Chemicals Ltd | 6.69 | 197.61 | Highly Overvalued | 137.00 | 17.15 | 29.00 |
| 11 | Yasho Industries Ltd | 6.09 | 203.81 | Neutral | 143.00 | 17.81 | 25.00 |
| 12 | Camlin Fine Sciences Ltd | 5.80 | 70.93 | Neutral | 107.00 | -1.72 | 24.00 |
| 13 | NOCIL Ltd | 5.27 | 50.94 | Neutral | 101.00 | 3.84 | 56.00 |
| 14 | Chemplast Sanmar Ltd | 4.81 | -9.62 | Neutral | 198.00 | -63.46 | -280.00 |
| 15 | Godavari Biorefineries Ltd | 4.15 | 340.51 | Neutral | 127.00 | 0.24 | 4.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤10th Nov 25
Q2 and H1 FY26 Earnings Call
NEUTRAL SENTIMENT
No Stock News Available at This Moment.
Camlin Fine Sciences Ltd is a global manufacturer of specialty chemicals, primarily offering shelf-life solutions for food, feed, and personal care industries. The company also produces performance chemicals and aroma ingredients, leveraging its strong R&D and integrated manufacturing capabilities to serve diverse international markets.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Camlin Fine Sciences Ltd's P/E ratio (TTM) is -59.38, compared to the industry median of 39.73 and large cap median of 37.95.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Camlin Fine Sciences Ltd's P/B ratio is 1.88, compared to the industry median of 2.59 and large cap median of 2.40.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Camlin Fine Sciences Ltd's P/S ratio is 1.08, compared to the industry median of 2.52 and large cap median of 2.34.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Camlin Fine Sciences Ltd's PEG ratio is 1.63.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Camlin Fine Sciences Ltd's EV/EBITDA ratio is 12.37.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Camlin Fine Sciences Ltd's ROE is 2.31%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Camlin Fine Sciences Ltd's ROA is 4.60%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Camlin Fine Sciences Ltd's ROCE is 4%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Camlin Fine Sciences Ltd's operating margin is 6.21%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Camlin Fine Sciences Ltd's net margin is 1.39%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Camlin Fine Sciences Ltd's current ratio is 1.48.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Camlin Fine Sciences Ltd's debt-to-equity ratio is 0.33.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Camlin Fine Sciences Ltd's interest coverage ratio is 1.32.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Camlin Fine Sciences Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Camlin Fine Sciences Ltd's EPS is 119.46.
(Source line: "Ratios as of 08 Oct 2026, based on last traded price of ₹102.14. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1993 (as Camlin Fine Chemicals Ltd)
Headquarters: Mumbai, Maharashtra
Core Offerings: Antioxidants, Vanillin & Ethyl Vanillin, Blended Antioxidant Solutions, Performance Chemicals
Stock Listing: NSE (CAMLINFINE), BSE (532834)
Promoter: Dandekar Family / Camlin Group
1993: Incorporated as Camlin Fine Chemicals Ltd. 1994: Commenced production of industrial chemicals. 2001: Launched food grade antioxidants, entering the food ingredients market. 2006: Company renamed to Camlin Fine Sciences Ltd, reflecting its broader scientific focus. 2010: Acquired an Italian food ingredients facility, marking global expansion. 2014: Commissioned a new state-of-the-art Vanillin manufacturing plant in India. 2018: Acquired a 65% stake in Wuhan Praputra Chemical Co. Ltd., China, strengthening its global Vanillin business.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Human & Animal Nutrition | ~75% | Operating Profit |
| Performance Chemicals | ~25% | Operating Profit |
Human & Animal Nutrition: Focuses on producing shelf-life solutions (e.g., TBHQ, BHA, BHT, custom antioxidant blends) and aroma ingredients (Vanillin, Ethyl Vanillin) critical for food, feed, and pharmaceutical applications.
Performance Chemicals: Manufactures specialty intermediates such as Guaiacol and its derivatives, catering to pharmaceutical, agrochemical, and other industrial sectors.
Integrated Manufacturing: Operates multiple facilities globally, including in India, Italy, China, and Brazil, ensuring diversified production capabilities and supply chain resilience.
Mr. Ashish Dandekar (Chairman & Managing Director): A chemical engineer, he has been a driving force behind the company's strategic vision, operational excellence, and global market expansion since its inception.
CFS Europe SpA (Italy) Camlin Fine Sciences (Thailand) Co. Ltd. PT CFS Indonesia CFS do Brasil Industria e Comercio de Produtos Quimicos Ltda (Brazil) CFS Inc. (USA) Wuhan Praputra Chemical Co. Ltd. (China) - majority stake CFS South Africa (Pty) Ltd. CFS (Mauritius) Ltd.
Rights Issue (2021) at a ratio of 1:13 for ₹100 per share.
The Camlin Fine Sciences Ltd share price today is ₹102.14 on NSE (CAMLINFINE), as of 08 Oct 2026.
As of 08 Oct 2026, Camlin Fine Sciences Ltd share price is ₹102.14, with previous close ₹102.14. Today's range is ₹102.14 to ₹102.14. The 52-week range is ₹N/A to ₹N/A.
As of today, Camlin Fine Sciences Ltd's market cap is ₹1,863.03 crore (Small Cap).
Camlin Fine Sciences Ltd's current P/E ratio is -59.38, compared to the CHEMICALS & PETROCHEMICALS sector average of 33.50.
Camlin Fine Sciences Ltd's current P/B ratio is 1.88.
Camlin Fine Sciences Ltd's current dividend yield is N/A. Last dividend of ₹0.60 per share was declared on 19-Aug-2023.
Camlin Fine Sciences Ltd's EPS (TTM) is ₹119.46.
Camlin Fine Sciences Ltd is a global manufacturer of specialty chemicals, primarily offering shelf-life solutions for food, feed, and personal care industries. The company also produces performance chemicals and aroma ingredients, leveraging its strong R&D and integrated manufacturing capabilities to serve diverse international markets.
Camlin Fine Sciences Ltd is promoted by Dandekar Family / Camlin Group, holding 48.03% as of 08 Oct 2026.
Camlin Fine Sciences Ltd is listed on NSE (CAMLINFINE) and BSE (532834). Its next quarterly results are expected on Q1 FY25 (expected Aug 2024).